The DOI matches its Crossref record; 94 of the 94 references it cites were found in a registry or an index.
Gram-positive bacterial cell envelopes: The impact on the activity of antimicrobial peptides
Open accessAbstract
A number of cationic antimicrobial peptides, effectors of innate immunity, are supposed to act at the cytoplasmic membrane leading to permeabilization and eventually membrane disruption. Thereby, interaction of antimicrobial peptides with anionic membrane phospholipids is considered to be a key factor in killing of bacteria. Recently, evidence was provided that killing takes place only when bacterial cell membranes are completely saturated with peptides. This adds to an ongoing debate, which role cell wall components such as peptidoglycan, lipoteichoic acid and lipopolysaccharide may play in the killing event, i.e. if they rather entrap or facilitate antimicrobial peptides access to the cytoplasmic membrane. Therefore, in this review we focused on the impact of Gram-positive cell wall components for the mode of action and activity of antimicrobial peptides as well as in innate immunity. This led us to conclude that interaction of antimicrobial peptides with peptidoglycan may not contribute to a reduction of their antimicrobial activity, whereas interaction with anionic lipoteichoic acids may reduce the local concentration of antimicrobial peptides on the cytoplasmic membrane necessary for sufficient destabilization of the membranes and bacterial killing. Further affinity studies of antimicrobial peptides toward the different cell wall as well as membrane components will be needed to address this problem on a quantitative level. This article is part of a Special Issue entitled: Antimicrobial peptides edited by Karl Lohner and Kai Hilpert.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Antimicrobial peptides of multicellular organisms
Zasloff, M. (2002) · Nature · doi:10.1038/415389a · Cited by 8,457
Mechanisms of Antimicrobial Peptide Action and Resistance
Yeaman, M. R., & Yount, N. Y. (2003) · Pharmacological Reviews · doi:10.1124/pr.55.1.2 · Cited by 3,001
Mode of action of membrane active antimicrobial peptides
Shai, Y. (2002) · Peptide Science · doi:10.1002/bip.10260 · Cited by 1,576
Beceiro, A., Tomás, M., & Bou, G. (2013) · Clinical Microbiology Reviews · doi:10.1128/cmr.00059-12 · Cited by 1,070
Describing the Mechanism of Antimicrobial Peptide Action with the Interfacial Activity Model
Wimley, W. C. (2010) · ACS Chemical Biology · doi:10.1021/cb1001558 · Cited by 1,001
Peschel, A., Otto, M., Jack, R. W., Kalbacher, H., Jung, G., & Götz, F. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.13.8405 · Cited by 994
Cationic peptides: effectors in innate immunity and novel antimicrobials
Hancock, R. E. (2001) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(01)00092-5 · Cited by 978 · cited 2×
“A number of AMPs, effectors of innate immunity [82] are potent in prevention of sepsis and inflammation as they particularly can neutralize LTA and inhibit LTA-induced cytokine release.”
BackgroundEFFECT OF TEMPERATURE ON THE COMPOSITION OF FATTY ACIDS IN ESCHERICHIA COLI
Marr, A. G., & Ingraham, J. L. (1962) · Journal of Bacteriology · doi:10.1128/jb.84.6.1260-1267.1962 · Cited by 730
Antimicrobial peptides: linking partition, activity and high membrane-bound concentrations
Melo, M. N., Ferre, R., & Castanho, M. A. R. B. (2009) · Nature Reviews Microbiology · doi:10.1038/nrmicro2095 · Cited by 709
Zinser, E., Sperka-Gottlieb, C. D., Fasch, E. V., Kohlwein, S. D., Paltauf, F., & Daum, G. (1991) · Journal of Bacteriology · doi:10.1128/jb.173.6.2026-2034.1991 · Cited by 704
Lipid II as a target for antibiotics
Breukink, E., & de Kruijff, B. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2004 · Cited by 701
Role of lipids in the interaction of antimicrobial peptides with membranes
Teixeira, V., Feio, M. J., & Bastos, M. (2012) · Progress in Lipid Research · doi:10.1016/j.plipres.2011.12.005 · Cited by 692
Immune modulation by multifaceted cationic host defense (antimicrobial) peptides
Hilchie, A. L., Wuerth, K., & Hancock, R. E. W. (2013) · Nature Chemical Biology · doi:10.1038/nchembio.1393 · Cited by 601
The Outer Membrane of Gram-negative Bacteria
Nikaido, H., & Nakae, T. (1980) · Advances in Microbial Physiology · doi:10.1016/s0065-2911(08)60208-8 · Cited by 587
ALTERATIONS IN OUTER MEMBRANE PERMEABILITY
Hancock, R. E. W. (1984) · Annual Review of Microbiology · doi:10.1146/annurev.mi.38.100184.001321 · Cited by 564
Structures of the Toll-like Receptor Family and Its Ligand Complexes
Jin, M. S., & Lee, J.-O. (2008) · Immunity · doi:10.1016/j.immuni.2008.07.007 · Cited by 558
Sg, W. (1988) · Medical Entomology and Zoology · Cited by 554
Alternative mechanisms of action of cationic antimicrobial peptides on bacteria
Hale, J. D., & Hancock, R. E. (2007) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.5.6.951 · Cited by 549
Composition of phospholipids and of phospholipid fatty acids and aldehydes in human red cells
Dodge, J. T., & Phillips, G. B. (1967) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)38890-8 · Cited by 464
Lipoteichoic Acid Synthesis and Function in Gram-Positive Bacteria
Percy, M. G., & Gründling, A. (2014) · Annual Review of Microbiology · doi:10.1146/annurev-micro-091213-112949 · Cited by 461
Role of lipoteichoic acid in infection and inflammation
Ginsburg, I. (2002) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(02)00226-8 · Cited by 425
Brötz, H., Josten, M., Wiedemann, I., Schneider, U., Götz, F., Bierbaum, G., & Sahl, H. (1998) · Molecular Microbiology · doi:10.1046/j.1365-2958.1998.01065.x · Cited by 421
(1997) · Springer eBooks · doi:10.1007/978-3-662-07548-7 · Cited by 403
The permeability of the wall fabric of Escherichia coli and Bacillus subtilis
Demchick, P., & Koch, A. L. (1996) · Journal of Bacteriology · doi:10.1128/jb.178.3.768-773.1996 · Cited by 389
Kamio, Y., & Nikaido, H. (1976) · Biochemistry · doi:10.1021/bi00657a012 · Cited by 368
The plasma membrane of Saccharomyces cerevisiae: structure, function, and biogenesis
van der Rest, M. E., Kamminga, A. H., Nakano, A., Anraku, Y., Poolman, B., & Konings, W. N. (1995) · Microbiological Reviews · doi:10.1128/mmbr.59.2.304-322.1995 · Cited by 358
Structural Biology of the Toll-Like Receptor Family
Kang, J. Y., & Lee, J.-O. (2011) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-052909-141507 · Cited by 331
Antibacterial membrane attack by a pore-forming intestinal C-type lectin
Mukherjee, S., Zheng, H., Derebe, M. G., Callenberg, K. M., Partch, C. L., Rollins, D., Propheter, D. C., Rizo, J., Grabe, M., Jiang, Q.-X., et al. (2014) · Nature · doi:10.1038/nature12729 · Cited by 325
Abachin, E., Poyart, C., Pellegrini, E., Milohanic, E., Fiedler, F., Berche, P., & Trieu‐Cuot, P. (2002) · Molecular Microbiology · doi:10.1046/j.1365-2958.2002.02723.x · Cited by 315
Findlay, B., Zhanel, G. G., & Schweizer, F. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00530-10 · Cited by 301
Molecular organization of Gram-negative peptidoglycan
Gan, L., Chen, S., & Jensen, G. J. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0808035105 · Cited by 292
Physiology of Lipoteichoic Acids in Bacteria
Fischer, W. (1988) · Advances in Microbial Physiology · doi:10.1016/s0065-2911(08)60349-5 · Cited by 262
Pichler, H., Gaigg, B., Hrastnik, C., Achleitner, G., Kohlwein, S. D., Zellnig, G., Perktold, A., & Daum, G. (2001) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2001.02116.x · Cited by 259
Vollmer, W., & Höltje, J.-V. (2004) · Journal of Bacteriology · doi:10.1128/jb.186.18.5978-5987.2004 · Cited by 258
Collins, L. V., Kristian, S. A., Weidenmaier, C., Faigle, M., van Kessel, K. P. M., van Strijp, J. A. G., Götz, F., Neumeister, B., & Peschel, A. (2002) · The Journal of Infectious Diseases · doi:10.1086/341454 · Cited by 251
Cell wall peptidoglycan architecture in Bacillus subtilis
Hayhurst, E. J., Kailas, L., Hobbs, J. K., & Foster, S. J. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804138105 · Cited by 245
Švajger, U., Anderluh, M., Jeras, M., & Obermajer, N. (2010) · Cellular Signalling · doi:10.1016/j.cellsig.2010.03.018 · Cited by 244
Lohner, K., & Blondelle, S. (2005) · Combinatorial Chemistry & High Throughput Screening · doi:10.2174/1386207053764576 · Cited by 222
Self-citationL-form bacteria, cell walls and the origins of life
Errington, J. (2013) · Open Biology · doi:10.1098/rsob.120143 · Cited by 198
New strategies for novel antibiotics: peptides targeting bacterial cell membranes
Lohner, K. (2009) · General Physiology and Biophysics · doi:10.4149/gpb_2009_02_105 · Cited by 188
Self-citationPeptidoglycan architecture of Gram-positive bacteria by solid-state NMR
Kim, S. J., Chang, J., & Singh, M. (2015) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2014.05.031 · Cited by 182
Oritavancin Kills Stationary-Phase and Biofilm Staphylococcus aureus Cells In Vitro
Belley, A., Neesham-Grenon, E., McKay, G., Arhin, F. F., Harris, R., Beveridge, T., Parr, T. R., & Moeck, G. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00766-08 · Cited by 178
Nell, M. J., Tjabringa, G. S., Wafelman, A. R., Verrijk, R., Hiemstra, P. S., Drijfhout, J. W., & Grote, J. J. (2006) · Peptides · doi:10.1016/j.peptides.2005.09.016 · Cited by 174
Covalent binding of the natural antimicrobial peptide indolicidin to DNA abasic sites
Marchand, C., Krajewski, K., Lee, H.-F., Antony, S., Johnson, A. A., Amin, R., Roller, P., Kvaratskhelia, M., & Pommier, Y. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkl667 · Cited by 171
Oku, Y., Kurokawa, K., Matsuo, M., Yamada, S., Lee, B.-L., & Sekimizu, K. (2009) · Journal of Bacteriology · doi:10.1128/jb.01221-08 · Cited by 169
Oritavancin: Mechanism of Action
Zhanel, G. G., Schweizer, F., & Karlowsky, J. A. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cir920 · Cited by 167
Poyart, C., Pellegrini, E., Marceau, M., Baptista, M., Jaubert, F., Lamy, M., & Trieu‐Cuot, P. (2003) · Molecular Microbiology · doi:10.1046/j.1365-2958.2003.03655.x · Cited by 165
Saar-Dover, R., Bitler, A., Nezer, R., Shmuel-Galia, L., Firon, A., Shimoni, E., Trieu-Cuot, P., & Shai, Y. (2012) · PLoS Pathogens · doi:10.1371/journal.ppat.1002891 · Cited by 164
Molecular basis for peptidoglycan recognition by a bactericidal lectin
Lehotzky, R. E., Partch, C. L., Mukherjee, S., Cash, H. L., Goldman, W. E., Gardner, K. H., & Hooper, L. V. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0909449107 · Cited by 164
Vijayrajratnam, S., Nisha, N., Biswas, L., Kumar, V. A., & Biswas, R. (2013) · Microbiological Research · doi:10.1016/j.micres.2013.02.005 · Cited by 162
Peptidoglycan recognition proteins of the innate immune system
Guan, R., & Mariuzza, R. A. (2007) · Trends in Microbiology · doi:10.1016/j.tim.2007.01.006 · Cited by 158
Dathe, M., Meyer, J., Beyermann, M., Maul, B., Hoischen, C., & Bienert, M. (2002) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(01)00429-1 · Cited by 157
The endothelin system in septic and endotoxin shock
Wanecek, M., Weitzberg, E., Rudehill, A., & Oldner, A. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00675-0 · Cited by 153
Interaction of Cationic Peptides with Lipoteichoic Acid and Gram-Positive Bacteria
Scott, M. G., Gold, M. R., & Hancock, R. E. W. (1999) · Infection and Immunity · doi:10.1128/iai.67.12.6445-6453.1999 · Cited by 153
Phospholipid Composition of Bacillus subtilis
den Kamp, J. A. F. O., Redai, I. G., & Deenen, L. L. M. V. (1969) · Journal of Bacteriology · doi:10.1128/jb.99.1.298-303.1969 · Cited by 149
The bacterial envelope as a target for novel anti-MRSA antibiotics
Françoise Van Bambeke, A., Mingeot‐Leclercq, M., Struelens, M. J., & Tulkens, P. M. (2008) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2007.12.004 · Cited by 149
Architecture and assembly of the G ram‐positive cell wall
Beeby, M., Gumbart, J. C., Roux, B., & Jensen, G. J. (2013) · Molecular Microbiology · doi:10.1111/mmi.12203 · Cited by 144
Koch, H.-G., Renate, H. A. A. S., & Fischer, W. (1984) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1984.tb07923.x · Cited by 137
Mishra, N. N., & Bayer, A. S. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02182-12 · Cited by 137
Lipoteichoic Acid Is Important in Innate Immune Responses to Gram-Positive Bacteria
Seo, H. S., Michalek, S. M., & Nahm, M. H. (2007) · Infection and Immunity · doi:10.1128/iai.01140-07 · Cited by 129
Münch, D., & Sahl, H. (2015) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2015.04.014 · Cited by 128
Lipid II: A central component in bacterial cell wall synthesis and a target for antibiotics
KRUIJFF, B. D., van Dam, V., & Breukink, E. J. (2008) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2008.09.020 · Cited by 127
Ginsburg, I. (2002) · Apmis · doi:10.1034/j.1600-0463.2002.1101101.x · Cited by 126
Phospholipid and sterol analysis of plasma membranes of azole-resistant Candida albicans strains
Löffler, J., Einsele, H., Hebart, H. F., Schumacher, U., Hrastnik, C., & Daum, G. ⁄. N. (2000) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.2000.tb09040.x · Cited by 124
How Many Antimicrobial Peptide Molecules Kill a Bacterium? The Case of PMAP-23
Roversi, D., Luca, V., Aureli, S., Park, Y., Mangoni, M. L., & Stella, L. (2014) · ACS Chemical Biology · doi:10.1021/cb500426r · Cited by 124
Torrent, M., Navarro, S., Moussaoui, M., Nogués, M. V., & Boix, E. (2008) · Biochemistry · doi:10.1021/bi702065b · Cited by 122
Belley, A. C., McKay, G. A., Arhin, F. F., Sarmiento, I., Beaulieu, S., Fadhil, I., Parr, T. R., & Moeck, G. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00760-10 · Cited by 120
Sevcsik, E., Pabst, G., Richter, W., Danner, S., Amenitsch, H. W., & Lohner, K. (2008) · Biophysical Journal · doi:10.1529/biophysj.107.123620 · Cited by 119
Self-citationExtractable Lipids of Gram-Negative Marine Bacteria: Phospholipid Composition
Oliver, J. D., & Colwell, R. R. (1973) · Journal of Bacteriology · doi:10.1128/jb.114.3.897-908.1973 · Cited by 117
Boix, E., & Nogués, M. V. (2007) · Molecular BioSystems · doi:10.1039/b617527a · Cited by 113
Antimicrobial peptides: to membranes and beyond
Marcos, J. F., & Gandía, M. (2009) · Expert Opinion on Drug Discovery · doi:10.1517/17460440902992888 · Cited by 111
White, D. A., Lennarz, W. J., & Schnaitman, C. A. (1972) · Journal of Bacteriology · doi:10.1128/jb.109.2.686-690.1972 · Cited by 108
Domènech, Ò., Francius, G., Tulkens, P. M., Françoise Van Bambeke, A., Dufrêne, Y. F., & Mingeot‐Leclercq, M. (2009) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2009.05.003 · Cited by 92
Lipid alterations in cell envelopes of polymyxin-resistant Pseudomonas aeruginosa isolates
Conrad, R. S., & Gilleland, H. E. (1981) · Journal of Bacteriology · doi:10.1128/jb.148.2.487-497.1981 · Cited by 86
Malanović, N., Leber, R., Schmuck, M., Kriechbaum, M., Cordfunke, R. A., Drijfhout, J. W., de Breij, A., Nibbering, P. H., Kolb, D., & Lohner, K. (2015) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2015.07.010 · Cited by 82
Self-citationKoprivnjak, T., Weidenmaier, C., Peschel, A., & Weiss, J. P. (2008) · Infection and Immunity · doi:10.1128/iai.01705-07 · Cited by 81
Li, Z., Zhang, S., Zhang, J., Liu, M., & Liu, Z. (2009) · Molecular Immunology · doi:10.1016/j.molimm.2009.08.006 · Cited by 79
Chemical biology of peptidoglycan acetylation and deacetylation
Moynihan, P. J., Sychantha, D., & Clarke, A. J. (2014) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2014.03.010 · Cited by 79
White, D. C. S., & Frerman, F. E. (1968) · Journal of Bacteriology · doi:10.1128/jb.95.6.2198-2209.1968 · Cited by 77
Arthur, M., Depardieu, F., Reynolds, P. E., & Courvalin, P. M. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.8.1875 · Cited by 77
Melo, M. N., & Castanho, M. A. R. B. (2007) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2007.02.005 · Cited by 74
Phospholipid and sterol analysis of plasma membranes of azole-resistant Candida albicans strains
Löffler, J. (2000) · FEMS Microbiology Letters · doi:10.1016/s0378-1097(00)00071-9 · Cited by 70
The Expanding Role of Lipid II as a Target for Lantibiotics
Martin, N. I., & Breukink, E. J. (2007) · Future Microbiology · doi:10.2217/17460913.2.5.513 · Cited by 69
Benamara, H., Rihouey, C., Abbes, I., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0108478 · Cited by 67
Topography Studies on the Membrane Interaction Mechanism of the Eosinophil Cationic Protein
Torrent, M., Cuyàs, E., Carreras, E., Navarro, S., Serrano, O. L., de la Maza, A., Nogués, M. V., Reshetnyak, Y. K., & Boix, E. (2006) · Biochemistry · doi:10.1021/bi061190e · Cited by 65
Courtney, H. S., Simpson, W. A., & Beachey, E. H. (1986) · Infection and Immunity · doi:10.1128/iai.51.2.414-418.1986 · Cited by 62
From Vancomycin to Oritavancin: The Discovery and Development of a Novel Lipoglycopeptide Antibiotic
Allen, N. E. (2010) · Anti-Infective Agents · doi:10.2174/187152110790886745 · Cited by 47
Small and medium‐angle X‐ray analysis of bacterial lipoteichoic acid phase structure
Labischinski, H., Naumann, D., & Fischer, W. (1991) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1991.tb16499.x · Cited by 43
Effect of lipoteichoic acid on thermotropic membrane properties
Gutberlet, T., Frank, J., Bradaczek, H., & Fischer, W. (1997) · Journal of Bacteriology · doi:10.1128/jb.179.9.2879-2883.1997 · Cited by 36
Promising antimicrobial agents designed from natural peptide templates
Henderson, J. M., & Lee, K. Y. C. (2013) · Current Opinion in Solid State and Materials Science · doi:10.1016/j.cossms.2013.08.003 · Cited by 31
Domènech, Ò., Dufrêne, Y. F., Françoise Van Bambeke, A., Tukens, P. M., & Mingeot‐Leclercq, M. (2010) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2010.06.011 · Cited by 28
Small‐Angle X‐Ray Scattering Analysis of Pneumococcal Lipoteichoic Acid Phase Structure
Fischer, W., Markwitz, S., & Labischinski, H. (1997) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1997.00913.x · Cited by 27
Sojcic, Z., Toplak, H., Zuehlke, R., et al. (1992) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(92)90128-9 · Cited by 24
Membrane-damaging activity with A chain and B chain of β-bungarotoxin
Liu, W., Kao, P.-H., Lin, S., & Chang, L. (2008) · Toxicon · doi:10.1016/j.toxicon.2008.11.012 · Cited by 6
Cited by
Antimicrobial peptides: mechanism of action, activity and clinical potential
Zhang, Q.-Y., Yan, Z.-B., Meng, Y.-M., Hong, X.-Y., Shao, G., Ma, J.-J., Cheng, X.-R., Liu, J., Kang, J., & Fu, C.-Y. (2021) · Military Medical Research · doi:10.1186/s40779-021-00343-2 · Cited by 1,065
Antimicrobial Peptides: Mechanisms of Action and Resistance
Bechinger, B., & Gorr, S.-U. (2017) · Journal of Dental Research · doi:10.1177/0022034516679973 · Cited by 739
β-lactam antibiotics: An overview from a medicinal chemistry perspective
Lima, L. M., Silva, B. N. M. D., Barbosa, G., & Barreiro, E. J. (2020) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2020.112829 · Cited by 642
Membrane Active Antimicrobial Peptides: Translating Mechanistic Insights to Design
Li, J., Koh, J.-J., Liu, S., Lakshminarayanan, R., Verma, C. S., & Beuerman, R. W. (2017) · Frontiers in Neuroscience · doi:10.3389/fnins.2017.00073 · Cited by 611
A broad-spectrum antibiotic adjuvant reverses multidrug-resistant Gram-negative pathogens
Song, M., Liu, Y., Huang, X., Ding, S., Wang, Y., Shen, J., & Zhu, K. (2020) · Nature Microbiology · doi:10.1038/s41564-020-0723-z · Cited by 484
Metadata
- Authors
- Malanovic, N., & Lohner, K.
- Venue
- Biochimica et Biophysica Acta (BBA) - Biomembranes
- Publisher
- Elsevier BV
- Published
- 2016-05
- Volume
- 1858
- Issue
- 5
- Pages
- 936-946
- ISSN
- 0005-2736 (ISSN-L)
- OpenAlex
- W2219394618
- Cited by
- 586
- References
- 94
- FWCI
- 21.53
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.